Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.40 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14184720 | 1.00 | NAAA (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL8512828 | 1.00 | NAAA (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL419534 | 1.00 | NAAA (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL27992732 | 1.00 | NAAA (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL4860823 | 1.00 | NAAA (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL31308 | 0.98 | NAAA (0.51) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| Hydrogen Sulfide SCHEMBL28268418 | 0.96 | NAAA (0.50) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL4573839 | 0.92 | NAAA (0.49) | NAAAKDM4EPIK3CDNR1H2ALDH1A1 | |
| SCHEMBL8516440 | 0.87 | PIK3CD (0.54) | NAAAKDM4EGBA1PTGS1PTGS2 | |
| SCHEMBL8157101 | 0.87 | FAAH (0.47) | NAAAKDM4EMGLLFAAHNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220061324-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-03-03 | — | — | US | disclosed |
| CN-112105341-A | A method for treating and/or preventing damaged keratin | 彼得·西夫勒 | 2020-12-18 | — | — | CN | disclosed |
| WO-1995015686-A1 | USE OF CARBAMIDE ACID ESTERS AS CRYSTALLISATION INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220061324-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | DDT, ACHE, AADAC | NAAA 280/4885KDM4E 2316/4885GBA1 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.